
Breast cancer sufferers will be granted extra months of life thanks to a new drug that has been approved for NHS use.
Enhertu, or trastuzumab deruxtecan, will be rolled out to 600 women a year in England. Trials have shown that that drug improves the survival of recipients by halting the spread of tumours.